Characterizing Ultrasound Vibroelastography Features of Ocular Tumors

Overview

About this study

The purpose of this study is to characterize ultrasound vibro-elastography features of ocular tumors.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients presenting for evaluation of an ocular tumor.
Age ≥18 years.
Any gender.
Have capacity to consent.

Exclusion Criteria:

Inability to provide informed consent.
Lack of an ocular tumor.
Lack of evaluation in the Mayo Clinic Rochester clinical practice.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/24/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Lauren Dalvin, M.D.	Open for enrollment	Contact information: Suzanne Wernimont CCRP (507) 538-8119 Wernimont.Suzanne@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lauren Dalvin, M.D.

Open for enrollment

Contact information:

Suzanne Wernimont CCRP

(507) 538-8119

Wernimont.Suzanne@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials